B. Alexeev

发表

Draft of Russian Guidelines of Diagnosis and Treatment of Adrenal Cortical Cancer

G. Melnichenko, V. Gorbunova, I. Stilidi, 2014 .

A phase 3, double-blind, randomized placebo-controlled efficacy and safety study of abiraterone acetate in chemotherapy-naïve patients with mCRPC in China, Malaysia, Thailand and Russia

F. Zhou, Yinghao Sun, D. Ye, 2017, Asian journal of urology.

Efficacy and safety of erdafitinib in patients with locally advanced or metastatic urothelial carcinoma: long-term follow-up of a phase 2 study.

T. H. Klotz, S. Culine, J. Hainsworth, 2022, The Lancet. Oncology.

Tivozanib versus sorafenib as initial targeted therapy for patients with advanced renal cell carcinoma: Results from a phase III randomized, open-label, multicenter trial.

R. Motzer, A. Berkenblit, C. Sternberg, 2012 .

Subcutaneous and orthotopic xenograft models of human bladder carcinoma in nude mice for epidermal growth factor receptor-targeted treatment

M. Vorontsova, M. Abakumov, N. Morozova, 2018, Russian Journal of Biotherapy.

Comparison of 2D and 3D cell cultures of colorectal adenocarcinoma as models for drug screening

I. Gaisina, L. Bolotina, A. Poloznikov, 2019, Russian Chemical Bulletin.

Experience of the use of mitotan in the combined treatment of adrenocortical cancer

G. Melnichenko, V. Gorbunova, I. Dedov, 2016 .

Tivozanib versus sorafenib as initial targeted therapy for patients with advanced renal cell carcinoma: Results from a phase III randomized, open-label, multicenter trial.

R. Motzer, A. Berkenblit, C. Sternberg, 2012 .

Luteinizing hormone releasing hormone analogues in the treatment of patients with prostate cancer

K. Nyushko, A. Kaprin, B. Alexeev, 2018, Medical Council.